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Backround: Aspartyl aminopeptidase (DNPEP), with specificity towards an acidic amino acid at the N-terminus, is
the only mammalian member among the poorly understood M18 peptidases. DNPEP has implicated roles in
protein and peptide metabolism, as well as the renin-angiotensin system in blood pressure regulation. Despite
previous enzyme and substrate characterization, structural details of DNPEP regarding ligand recognition and
catalytic mechanism remain to be delineated.
Results: The crystal structure of human DNPEP complexed with zinc and a substrate analogue aspartate-β-
hydroxamate reveals a dodecameric machinery built by domain-swapped dimers, in agreement with electron
microscopy data. A structural comparison with bacterial homologues identifies unifying catalytic features among
the poorly understood M18 enzymes. The bound ligands in the active site also reveal the coordination mode of the
binuclear zinc centre and a substrate specificity pocket for acidic amino acids.
Conclusions: The DNPEP structure provides a molecular framework to understand its catalysis that is mediated by
active site loop swapping, a mechanism likely adopted in other M18 and M42 metallopeptidases that form
dodecameric complexes as a self-compartmentalization strategy. Small differences in the substrate binding pocket
such as shape and positive charges, the latter conferred by a basic lysine residue, further provide the key to
distinguishing substrate preference. Together, the structural knowledge will aid in the development of enzyme-
/family-specific aminopeptidase inhibitors.
Keywords: Aspartyl aminopeptidase, Dodecameric tetrahedron, M18 peptidase, Metalloprotease, Domain swappingBackground
Aminopeptidases (APs) catalyze the sequential removal of
amino acids from the unblocked N-termini of protein or
peptide substrates, a process necessary for intracellular
metabolism [1] and implicated in several human diseases
[2]. Most APs are metalloproteases and are classified
based on substrate preference towards an acidic, basic or
neutral amino acid at the P1 position of the scissile pep-
tide bond. Very few acidic APs are known to date, the* Correspondence: wyatt.yue@sgc.ox.ac.uk
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reproduction in any medium, provided the ormost extensively studied being the membrane-bound glu-
tamyl aminopeptidase (ENPEP, also known as aminopepti-
dase A; EC 3.4.11.7) [3]. ENPEP, a membrane-bound
Ca2+-activated enzyme, is involved in the renin-
angiotensin system (RAS) by catalysing the conversion of
angiotensin II to angiotensin III, a key regulator of blood
pressure [4,5]. A second, cytosolic acidic AP has been
reported in yeast, fungi and mammals, and termed aspar-
tyl aminopeptidase (DNPEP, also known as DAP; EC
3.4.11.21) due to its preference for aspartate over glutam-
ate at the P1 position [6-8]. In mammals, DNPEP is pre-
ferentially expressed and has high enzymatic activity in
neurons and neuroendocrine tissues [6,9,10]. Its reportedal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of angiotensin II to angiotensin III [6] in vitro, implicates a
role in RAS and regulation of blood pressure. Moreover, a
mild antagonist effect of DNPEP towards the bone mor-
phogenetic protein signalling pathway has recently been
reported [11].
DNPEP is the sole mammalian entry for the M18
metallopeptidase family, which contains ~600 putative
members from bacteria and eukaryotes [12]. The M18
family, together with the M20, M28 and M42 families,
are classified into the metalloprotease H (MH) clan of
proteases on the basis of active site sequence conserva-
tion according to the MEROPS database [12,13]. Only a
handful of M18 enzymes have been biochemically char-
acterized in any detail; these include yeast vacuole ami-
nopeptidase I (API, also known as Lap4) with a broad
substrate specificity for non-polar amino acids [14], as
well as yeast yhr113w (also known as Ape4) [7] and
mammalian DNPEP which prefer an acidic amino acid.
These M18 enzymes are shown to homo-oligomerize,
reminiscent of the self-compartmentalization strategy in
the well-characterized proteasomes to confer specificity
towards unfolded polypeptides and not folded proteins
[15]. However, the reported dodecameric form in yeast
Lap4 and Ape4 [7,14] contrasts with the proposed octa-
meric form in DNPEP [6].
Little is known about the structure-function relation-
ship of DNPEP and other M18 members, which contain
a binuclear metal centre in the active site but lack the
signature Zn2+-binding sequence motif (HExxH+E)
found in other metalloproteases such as ENPEP [16]. Al-
though several conserved histidines essential for catalysis
have been identified in human DNPEP [17], their roles
are yet to be elucidated. In this study we determined
the crystal structure of human DNPEP (hDNPEP)
complexed with catalytic Zn2+ and substrate analogue
L-aspartate-β-hydroxamate (ABH), and confirmed its
dodecameric architecture by electron microscopy (EM).
The bound ABH ligand highlights the importance of a
domain-swapped loop in constructing the active site
and provides a structural basis for hDNPEP’s catalytic
mechanism and substrate specificity. By comparison
with available bacterial M18 structures we further de-
velop a family-wide description of this unannotated
peptidase family and suggest unifying catalytic features
across the MH clan.
Results & discussion
Overall structure of hDNPEP
The structure of the hDNPEP•Zn2+•ABH complex
(Figure 1A), determined at 2.2 Å resolution, is homolo-
gous to four unpublished bacterial M18 homologues
with undefined enzyme and substrate properties (DALI
Z-scores ~40, rmsd 1.9-2.7 Å and sequence identity 23-35%). Superposition of the structures reveals a common
two-domain architecture consisting of the proteolytic
and dimerization domains (Figure 1A and C), with the
active site located in a concave groove at the domain
interface. The globular proteolytic domain (aa 7–98 and
249–468 in hDNPEP) features a core nine-stranded β-
sheet sandwiched between several α-helices and has a
small five-stranded β-subdomain resting on top
(Figure 1A). This proteolytic domain is highly similar
among all M18 structures (rmsd ~1.5 Å). The
dimerization domain, contributed from the central poly-
peptide stretch (aa 99–248 in hDNPEP), sits on top of
the proteolytic domain (Figure 1A). This butterfly-
shaped domain is built of two orthogonal β-sheets (five-
and three-stranded respectively) that share in common
two tilted strands β5 and β6, and also includes an
extended β8-β9 loop that is important for active site
formation (see next sections). Variations in the
dimerization domain are observed among M18 enzymes,
particularly with the location and spatial orientation of
helices α3 and α4 and the connecting loop α3-α4. In
hDNPEP loop α3-α4 is longer than the bacterial equiva-
lents (Figure 1B), although it is partially disordered in
our structure.
Structural comparison of M18 hDNPEP with members
of other MH clan families (M20, M28 and M42)
(Figure 1D) shows that the proteolytic domains of all
four families can be superimposed well (pairwise rmsd
~2.3 Å), particularly in the core β-sheet and the binuc-
lear metal centre. This structural homology suggests an
evolutionarily-conserved strategy for metal coordination
and metal-assisted catalysis [13]. Away from the proteo-
lytic domain, however, the four families diverge structur-
ally in the dimerization domain, with M28 members
lacking this domain altogether (Figure 1D, right), a fact
that is reflected in their different oligomeric states. The
hDNPEP dimerization domain exhibits closer topology
and orientation to the dodecameric M42 enzymes
(Figure 1D, bottom) [18-20], but has distinct fold and
tertiary arrangements compared to the counterpart do-
main in M20 members (Figure 1D, top) that are known
monomers or dimers [21,22]. This observation suggests
a closer structural relationship of M18 with M42
enzymes, than with M20 or M28 members, a feature not
apparent from sequence-based comparisons. This is fur-
ther supported by M18 and M42 members sharing simi-
lar oligomeric assembly and active site architecture (see
following sections).
hDNPEP dodecameric tetrahedron
Application of the crystallographic 432 symmetry to the
hDNPEP monomer results in a tetrahedron-shaped
dodecamer built from six homodimers, a quaternary ar-
rangement similar to M42 enzymes [15,18,19]. Each
Figure 1 Overview of hDNPEP structure. (A) hDNPEP protomer organizes into the dimerization (blue) and proteolytic domains, the latter is
further comprised of subdomain A (orange) and subdomain B (magenta). Zinc ions are shown as blue spheres and the ABH ligand as yellow
sticks. (B) Sequence alignment of DNPEP (human, h; bovine, b) and M18 aminopeptidases from yeast Saccharomyces cerevisiae Lap4 (ScLAP4),
yeast Ape4 (ScApe4) and two bacterial enzymes (Pseudomonas aeruginosa PaApeB and Thermotoga maritima TmApeA). Secondary structure
elements, catalytic residues (yellow) and residues in the P1 substrate pocket (cyan) of hDNPEP are highlighted. Structural superimposition of
hDNPEP with bacterial M18 APs (C) and with M20, M28 and M42 representatives from the MH clan (D) reveals highly conserved topology of the
proteolytic domain. The superimposed structures include M18 APs: Thermotoga maritima ApeA (TmApeA), Clostridium acetobutylicum ApeA
(CaApeA), Borrelia burgdorferi ApeA (BbApeA), Pseudomonas aeruginosa ApeB (PaApeB); M20 APs: Pseudomonas CPG2 (PsCPG2), Lactobacillus
delbrueckii PepV (LdPepV), Legionella pneumophila DapE (LpDapE); M28; Aeromonas proteolytica LAP (ApLAP), Streptomyces griseus Ap (SgApS); and
M42: Pyrococcus horikoshii TET1 and TET2 (PhTET1, PhTET2), Streptococcus pneumonia PepA (SpPepA). PDB IDs of all structures are given.
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and horizontal axes (Figure 2A), is formed by extensive
contacts that involve the swapping of loop β8-β9 be-
tween the two subunits (Additional file 1, Figure S1).Mediated by four-fold symmetry, the six dimers assem-
ble into a tetrahedron (Figure 2B), with each dimer con-
stituting one edge (~118 Å) of the tetrahedron
(Figure 2B, inset). The tetrahedron has a 50 Å-diameter
Figure 2 Dodecameric assembly. (A) A dimer building block of hDNPEP. (B) Surface representation of the arrangement of six dimers into
a tetrahedron. The dimer building block, each coloured differently, is delineated by a red dotted line. The black-dotted line indicates the
monomer-monomer interface within a dimer. Each dimer sits diagonally on six faces of a cubic box that encases the tetrahedron (red line, inset).
Asterisks indicate positions of the narrow (yellow) and wide (blue) channels, which are located at 3-fold axes (arrow). (C) The openings of the
narrow (top) and wide (bottom) channels. (D) Electron micrograph of negatively stained hDNPEP. (E) Examples of 2D classification images with a
view down the wide channel, the 3-fold symmetry imposed in the right panel. (F) Fitting of hDNPEP crystal structure onto the 2D projection.
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accessible to the exterior through four wide and four
narrow channels situated on the three-fold axes. The
entrances of the wide channels, a triangular pore of
28 Å per side, are located at the centre of the four tetra-
hedron facets (Figure 2B and C, blue asterisks), while
the four narrow channels have their openings (9 Å per
side) on the four tetrahedron vertexes (Figure 2B and C,
yellow asterisks).
The hDNPEP dodecamer contrasts with an octameric
arrangement previously deduced from native PAGE ana-
lysis [6]. As an independent verification we performed
EM image analysis, revealing one homogeneous particle
population on micrographs (Figure 2D) with characteris-
tic patches of density surrounding a hole in the middle,
corresponding to the 3-fold symmetrical view down the
wide channels at a facet of the tetrahedron complex on
the 2D classification (Figure 2E). The tetrahedron shape
and dimensions from the EM projection are in excellent
agreement with the crystallographic dodecamer
(Figure 2F), lending support to its physiologicallyrelevance. While the oligomeric state of the bacterial
M18 homologues is not reported, their crystal structures
suggest the formation of dodecameric tetrahedrons simi-
lar to hDNPEP (Additional file 1, Figure S2), pointing to-
wards a common self-compartmentalization strategy for
catalysis.
Architecture of wide and narrow channels
We next performed an analysis of the wide and narrow
channels in hDNPEP that represent the only access
route between the twelve active sites in the central
chamber and the exterior. Both channels in M18
hDNPEP are remarkably similar in topology to the M42
dodecameric tetrahedrons. The wide channels, each
formed from three dimers (Additional file 1, Figure S3),
are 20 Å in width and 28 Å in length with a large con-
cave surface at the entrance lined by positively-charged
residues (Figures 3A and 3B). This wide channel, sup-
ported by the positive electrostatic environment that
would complement the substrate acidic N-termini, likely
functions as an entrance for unfolded peptide substrates.
Figure 3 Architecture of wide (top) and narrow (bottom) channels. (A) Electrostatic surface of the wide channel with yellow line indicating
the 28-Å route connecting the exterior and the central chamber. (B) Details of residues lining the wide channel, showing only one set of residues
from one dimer. (C) Electrostatic surface along the 33-Å length of the narrow channel. (D) Details of residues lining the narrow channel. Bound
glycerol (GOL) and magnesium (Mg) molecules are shown in stick and sphere, respectively.
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mentarity as a basis for substrate discrimination, has
been proposed for M42 tetrahedron aminopeptidases
[18,23,24]. Consistent with this theory, mutation of
His363 (one of the residues lining the channel) to a non-
polar residue has an adverse effect on the hDNPEP kin-
etic property [17].
The narrow channels (Figure 3C) are located at the
interface of three monomers that are constituents of dif-
ferent dimers, giving rise to an inner helical bundle with a
β-barrel-like outer casing (Figure 3D and Additional file 1,
Figure S3). The essential nature of this channel has been
demonstrated for some tetrahedron aminopeptidases [23].
In hDNPEP, we observed water, glycerol molecules and a
hydrated Mg2+ ion within this channel (Figure 3C and D),
suggesting a possible route for small molecules such as
cleaved amino acids to exit after hydrolysis [23]. The nar-
row channel may also provide a path for the translocation
of metal ions (e.g. catalytic zinc), mediated by layers of
charged residues within the channel. However, to achieve
either transit function, slight conformational changes may
be required to open up the channel pore considering its
narrow width (~3 Å)(Figure 3C).Metal-dependent active site
The active site is defined by the bound substrate
analogue ABH and two zinc ions (Zn1 and Zn2)
(Figure 4A and B) – the latter likely carried through pro-
tein expression and purification, and confirmed by fluor-
escence absorption profile of the crystals (data not
shown). Zn1 and Zn2, bridged by Asp264, are 3.4 Å
apart, consistent with the distances observed in other
binuclear metalloproteases [13]. Zn1 is further coordi-
nated by Glu302 and His440, and Zn2 by His94 and
Asp346 (Figure 4C). These five metal coordinating resi-
dues (His94, Asp264, Glu302, Asp346 and His440) form
a ‘H.D.E.D.H’ signature strictly conserved among DNPEP
paralogues and M18 members (Figure 1B), providing an
explanation for the abolished hDNPEP activity by muta-
tions of His94 and His440 [17].
Additional coordination to the binuclear zinc is pro-
vided by the bound ABH molecule, a competitive inhibitor
of hDNPEP [6,17]. ABH binds to the active site with the
hydroxamate moiety towards the binuclear metal centre
to contribute its carbonyl and hydroxyl oxygen atoms for
zinc coordination (Figure 4C), while its amino-acid back-
bone protrudes into a cavity often known as the P1
Figure 4 Active site of hDNPEP. (A) |FO|- |Fc| omit map contoured at 3σ for zinc ions and ABH molecules. (B) Insertion of the β8-β9 loop from
the neighboring subunit (magenta) completes the active site construction. Bonding interactions at (C) the binuclear metal catalytic centre and (D)
the P1 substrate pocket in the hDNPEP structure. (E) Proposed catalytic mechanism for hDNPEP. The substrate peptide N-terminus is shown in
both amine and its protonated form, which can engage in different interactions.
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direct or water-mediated hydrogen bonds to Glu301 and
Asp346 via the hydroxamate moiety, and to Tyr381,
Lys374 and His349 via the amino acid backbone
(Figure 4D). Of particular interest is an interaction be-
tween the hydroxamate carbonyl oxygen and His170 from
the opposing subunit (His170b) of a dimer (Figure 4D).
His170b sits at the tip of the β8-β9 loop from the neigh-
bouring subunit that crosses over to complete the active
site (Figure 4B and Additional file 1, Figure S1). Such loop
swapping to translocate a distant ligand-binding residue
into the active site is crucial to hDNPEP catalysis, as evi-
dent by a complete abolishment of activity in a His170Phe
mutant [17]. This histidine residue is also conserved in
M42 enzymes, although in the available M42 structures
the equivalent loops are disordered or partially disordered.
This disorder could be due to the lack of bound substrate/
analogue, suggesting a substrate-induced conformational
reorientation is necessary to complete the catalytic centre.
Conservation of this histidine therefore implies that the
loop-swapped active site is a common structural feature
among M18 and M42 dodecamers built from dimeric
units.
A possible catalytic mechanism for M18 hDNPEP is
proposed (Figure 4E), on the assumption that the hydro-
xylamine nitrogen and carbonyl oxygen of the ABH
hydroxamate represent where the amine and carbonyl
groups of the substrate peptide would be coordinated by
Zn2 and Zn1, respectively. A nucleophilic water moleculecould feasibly occupy the position of the ABH hydroxyl
oxygen and would be activated by Glu301 to attack the
scissile bond. His170b can function to bind the peptide
carbonyl oxygen and stabilize the tetrahedral intermediate.
This mechanism is consistent with that proposed for other
metallopeptidases [13].
Structure basis for hDNPEP substrate specificity
The bound ABH provides a template to build dipeptide
models of Asp-Ala and Glu-Ala into the active site in
order to rationalize hDNPEP substrate specificity. For
both peptides, the Asp and Glu sidechains fit into the P1
substrate pocket without steric constraints, while the
mainchain is modeled onto the hydroxamate group of
ABH in a position optimal for hydrolysis. The P1 sub-
strate pocket (Additional file 1, Figure S4A) is created by
strand β15 and the β16-α12 and β17-α13 loops, with the
β17-α13 loop lining the wall and restricting the dimen-
sions of the pocket. This limited space disfavours bulky
hydrophobic residues, as illustrated by a structural com-
parison with the P1 pockets in M28 neutral aminopepti-
dases where the equivalent loop is displaced away from
the P1 pocket thereby generating a large cavity for bulky
residues such as Phe and Met (Additional file 1, Figure
S4B and C).
The modelled Asp and Glu sidechains can engage in
slightly different interactions with hDNPEP (Additional
file 1, Figure S5). While the Asp carboxylate feasibly
interacts with Lys374 and forms water-mediated
Figure 5 Structural comparison of the P1 pockets in hDNPEP and bacterial M18 members. (A-C) Three bacterial M18 AP structures (PDB
ids in brackets) are superimposed onto hDNPEP, with particular focus on the P1 substrate pocket. This highlights variations not only in shape but
also residue compositions for the P1 pocket, and may be correlated with different substrate specificities and enzyme activities among M18
enzymes. (D) A structure-based sequence alignment shows no conservation of four key residues of the hDNPEP P1 pocket among the bacterial
M18 enzymes, in particular Lys374 likely to be a determinant for acidic amino acid preference.
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can further penetrate this cavity and interact directly
with Lys374, His349 and the nearby Tyr381. Our sub-
strate models suggest that the strict preference for an
acidic amino acid at the P1 position is conferred by
positively-charged and polar residues, such as Lys374
and His349. The use of electrostatic complementarity
for substrate selectivity has precedence in the M42 pep-
tidase SpPepA [20]. Consistent with this strategy, muta-
tion of His349 in hDNPEP has been shown to weaken
substrate binding affinity [17]. Furthermore, the conser-
vation of Lys374 only in M18 members with acidic ami-
nopeptidase activity (e.g. yeast Ape4), but not in M18
‘promiscuous’ peptidases (e.g. yeast Lap4, where the
equivalent is Ser) (Figure 1B), provides a structure-based
criteria to classify putative M18 sequences into potential
aspartyl aminopeptidases (Lys374 conserved) or non-
aspartyl aminopeptidases (Lys374 not conserved), facili-
tating subsequent enzymatic characterization. Using this
criteria we propose that the structurally characterized
bacterial M18 members, where the equivalent Lys374
positions are substituted (Figure 5), are unlikely to be
aspartyl aminopeptidases.
Conclusion
In summary, we provide a structural annotation of the
M18 metallopeptidase family, highlighting commoncatalytic residues and oligomeric properties. In particu-
lar, a loop-swapped active site utilizing a residue from an
adjacent subunit for catalysis is likely a common charac-
teristic among M18 and M42 dodecameric aminopepti-
dases. Furthermore, the bound substrate analogue in the
active site provides insight into the reaction mechanism
and substrate specificity for hDNPEP, facilitating the
next steps in the development of family-specific small-
molecule binders to further probe its cellular role in
metabolic pathways and disease.
Methods
Cloning, expression and protein purification
A DNA fragment encoding hDNPEP aa 1–468 (Uniprot
ID: Q9ULA0) was sub-cloned into the pNIC-CTHF vec-
tor, incorporating a C-terminal His6-tag and TEV prote-
ase site. The recombinant protein was expressed in E.
coli BL21(DE3)-R3 by induction with 0.1 mM IPTG
overnight at 18°C. Cells were harvested and homoge-
nized in lysis buffer (50 mM HEPES pH 7.5, 500 mM
NaCl, 5 mM imidazole, 5% glycerol). Protein was puri-
fied by affinity (Ni-Sepharose) and size exclusion chro-
matography (Superdex 200). The affinity tag was
removed by His-tagged TEV protease and the TEV-
cleaved protein was passed over Ni-Sepharose resin.
Purified protein was stored at −80°C in 10 mM HEPES,
pH 7.5, 500 mM NaCl, 5% glycerol and 0.5 mM TCEP.
Table 1 Data Collection and Refinement Statistics
hDNPEP•Zn2+•ABH
PDB accession code 4DYO
Data collection
Beamline Diamond Light Source, I03
Wavelength (Å) 0.9763
Spacegroup F 432
Resolution rangea (Å) 56.11 – 2.20 (2.32 – 2.20)
Unit cell dimensions a= b = c= 224.60 Å;
α= β= γ= 90.0°
No. unique reflectionsa 32,192 (4,486)




a (%) 17.9 (83.3); 5.5 (29.7)
Redundancya 10.8 (8.0)
Wilson B factor (Å2) 28.5
Refinement





rms deviation bond lengthb (Å) 0.015




a Values in brackets show the statistics for the highest resolution shells.
b rms, root-mean-square.
c P/L/M/O indicate protein, ligand molecules in the active sites, metal zinc ions
and other molecules, respectively.
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hDNPEP (10 mg/ml) was pre-incubated with 5 mM L-
aspartate-β-hydroxamate (ABH) and crystallized by sit-
ting drop vapour diffusion at 20°C in a 150-nl drop by
mixing protein and reservoir solution (15% w/v PEG
3350, 0.25 M MgCl2 and 0.1 M Tris–HCl pH 8.0) in a
2:1 ratio. Crystals were cryo-protected with mother li-
quor supplemented with 25% glycerol and flash-cooled
in liquid nitrogen. Diffraction data were collected at
Diamond Light Source beamline I03, and processed
and scaled with MOSFLM and SCALA from the CCP4
suite [25].
Structure determination
hDNPEP crystals belong to the F-centered cubic space-
group F432 with unit cell parameters a,b,c = 224.6 Å and
α,β,γ= 90.0°. The asymmetric unit contains one hDNPEP
protomer. The structure was solved by molecular re-
placement using PHASER [26] and the Pseudomonas
aeruginosa M18 structure (PDB id: 2IJZ) as search
model. Density modification was performed using DM[27] and improved phases were used for automated
model building with ARP/wARP [28]. The structure was
refined using REFMAC [29] and rebuilt with COOT
[30]. Residues 1–6 and 204–213 are disordered and not
included in the final model. Data collection and refine-
ment statistics are summarized in Table 1.
Electron microscopy
hDNPEP at ~0.7 μM was applied to EM grids and stained
with 2% uranyl acetate. Electron micrographs were
recorded (x 45,000) using a FEI-Phillips CM120 EM.
Images were digitized on a Nikon Super Coolscan 9000
(step size of 12.5 μm with a pixel size of 2.78 Å). The
WEB and SPIDER software [31] were used for image
processing. 4,736 particles were windowed, subjected to
reference-free alignment, and sorted into classes using
the K-means clustering method [32]. Manual fitting of
the hDNPEP crystal structure into the 2D map was
achieved using CHIMERA [33].
Footnotes
The atomic coordinates and structure factors have been
deposited in the Protein Data Bank (http://www.rcsb.org/)
with accession number 4DYO.
Additional file
Additional file 1: Figure S1. Domain swapping inthe hDNPEP dimer.
Figure S2. Tetrahedron complexes of available bacterial M18 structures.
Figure S3. Architecture of the wide and narrow channels. Figure S4.
hDNPEP P1 substrate pocket. Figure S5. Substrate peptide modelling
into hDNPEP [34-37].
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